Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Полное описание

Библиографические подробности
Главные авторы:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Формат:	Journal article
Язык:	English
Опубликовано:	Wiley Open Access 2024

Схожие документы

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
по: Helia Givian, и др.
Опубликовано: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
по: Jorge Garcia Condado, и др.
Опубликовано: (2023-10-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
по: Oulhaj, A, и др.
Опубликовано: (2016)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
по: Michael J. Pearson, и др.
Опубликовано: (2024-07-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
по: Ali Azargoonjahromi, и др.
Опубликовано: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
по: Asma Hallab, и др.
Опубликовано: (2024-09-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
по: de Jager, C, и др.
Опубликовано: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
по: De Jager, C, и др.
Опубликовано: (2012)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
по: Chen Xue, и др.
Опубликовано: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
по: Chao Wang, и др.
Опубликовано: (2024-06-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
по: Xiaoming Zheng, и др.
Опубликовано: (2024-10-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
по: Lanlan Li, и др.
Опубликовано: (2021-01-01)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
по: Gerasimos Grammenos, и др.
Опубликовано: (2024-04-01)

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods
по: Baiwen Zhang, и др.
Опубликовано: (2024-06-01)

Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
по: Boyue Song, и др.
Опубликовано: (2024-01-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
по: Zhongzhe Ouyang, и др.
Опубликовано: (2024-03-01)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
по: Guanan Zhao, и др.
Опубликовано: (2024-01-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
по: Jones, S, и др.
Опубликовано: (2017)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
по: Stockman, CA, и др.
Опубликовано: (2024)

Longitudinal accelerated brain age in mild cognitive impairment and Alzheimer’s disease
по: Maria Ly, и др.
Опубликовано: (2024-10-01)

Associations of Serum Isoleucine with Mild Cognitive Impairment and Alzheimer’s Disease
по: Xiao-jun Jing, и др.
Опубликовано: (2024-09-01)

Sex Differences in Conversion Risk from Mild Cognitive Impairment to Alzheimer’s Disease: An Explainable Machine Learning Study with Random Survival Forests and SHAP
по: Alessia Sarica, и др.
Опубликовано: (2024-02-01)

Random forest prediction of Alzheimer's disease using pairwise selection from time series data
по: Moore, P, и др.
Опубликовано: (2019)

Classification of Alzheimer’s and MCI Patients from Semantically Parcelled PET Images: A Comparison between AV45 and FDG-PET
по: Seyed Hossein Nozadi, и др.
Опубликовано: (2018-01-01)

Brain age gap estimation using attention-based ResNet method for Alzheimer’s disease detection
по: Atefe Aghaei, и др.
Опубликовано: (2024-06-01)

Homocysteine, B vitamins, and cognitive impairment
по: Smith, A, и др.
Опубликовано: (2016)

Homocysteine, B vitamins, and cardiovascular disease
по: Refsum, H, и др.
Опубликовано: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
по: Refsum, H, и др.
Опубликовано: (2006)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
по: Smith, A, и др.
Опубликовано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
по: Smith, A, и др.
Опубликовано: (2010)

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.
по: Smith, A, и др.
Опубликовано: (2010)

Learning semi-supervised enrichment of longitudinal imaging-genetic data for improved prediction of cognitive decline
по: Hoon Seo, и др.
Опубликовано: (2024-05-01)

Disrupted single-subject gray matter networks are associated with cognitive decline and cortical atrophy in Alzheimer’s disease
по: Yaqiong Xiao, и др.
Опубликовано: (2024-05-01)

Multiple phenotype association tests based on sliced inverse regression
по: Wenyuan Sun, и др.
Опубликовано: (2024-04-01)

Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study.
по: Nurk, E, и др.
Опубликовано: (2005)

Quantifying uncertainty in brain-predicted age using scalar-on-image quantile regression
по: Palma, M, и др.
Опубликовано: (2020)

Impact of APOE-ε alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
по: Colleen Lacey, и др.
Опубликовано: (2024-01-01)

The Association among Hypothalamic Subnits, Gonadotropic and Sex Hormone Plasmas Levels in Alzheimer’s Disease
по: Edward Ofori, и др.
Опубликовано: (2024-03-01)

Uptake of 18F-AV45 in the Putamen Provides Additional Insights into Alzheimer’s Disease beyond the Cortex
по: Zhengshi Yang, и др.
Опубликовано: (2024-01-01)

Polygenic Score for Conscientiousness Is a Protective Factor for Reversion from Mild Cognitive Impairment to Normal Cognition
по: Xuan Yang, и др.
Опубликовано: (2024-08-01)